NINGBO IINNO PHARMCHEM CO.,LTD. was established in 2007. It is a high-tech pharmaceutical chemical company integrating R&D, production and sales. It is committed to the research and development, production and utilization of raw materials and intermediates, fine chemicals. Sales. The company team has 20 years of experience in R&D, production and management, and sales experience in domestic and foreign markets, striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.
Our current development direction of the company is based on integrated resources, supplemented by independent R&D and production, and unswervingly follow the path of virtual R&D and manufacturing. We sincerely welcomes cooperation with various R&D companies, R&D personnel and production companies.
Our company's R&D company, Ningbo Gino Chemical Co., Ltd. was established in December 2011. we have several fume hoods and kilogram laboratory, and have purchased 20L, 50L reactors and as a preliminary pilot manufacturing of the products. At the same time, We mobilized external resources to establish a pilot facility in Henan Zhumadian and Anhui Anqing, and cooperating with Shandong Zibo and Jiangsu Changzhou factories as a large production facility for our products.
At the end of 2017, We invested workshop in Xinjiang County Longzhou Chemical Co., Ltd., Xinjiang County Coal Mine Park, Yuncheng, Shanxi. The first phase of the reactors were 18* 000L~5000L, and 10 new reactors were planned. The contract output value is 40 million annually, factory has passed the audit from public listed company domestic and abroad.
The production base of liquid rectification chemical products located in Liaocheng, Shandong Province is the main outsourcing production base of our company. The products are sold to leading enterprises and listed companies in the carcass industry for many years. The production, quality and service are stable, delivery is timely, and some individual products are covering 90% of the market.